Entrada Therapeutics Inc
(TRDA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 78,527 | 23,496 | -6,685 | 2,859 | -32,602 |
| Depreciation Amortization | -2,454 | -1,103 | -2,938 | -1,675 | -657 |
| Accounts payable and accrued liabilities | -1,541 | -655 | -2,805 | -5,211 | -3,846 |
| Other Working Capital | -75,218 | -54,177 | 124,326 | 122,216 | 188,812 |
| Other Operating Activity | 15,000 | 6,920 | 27,905 | 25,627 | 16,601 |
| Operating Cash Flow | $14,314 | $-25,519 | $139,803 | $143,816 | $168,308 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,648 | 26,985 | -132,781 | -152,800 | -150,511 |
| PPE Investments | -1,884 | -838 | -5,614 | -4,638 | -3,190 |
| Investing Cash Flow | $1,764 | $26,147 | $-138,395 | $-157,438 | $-153,701 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 101,573 | 206 | 21,037 | 20,347 | 19,979 |
| Financing Cash Flow | $101,573 | $206 | $21,037 | $20,347 | $19,979 |
| Beginning Cash Position | 71,552 | 71,552 | 49,107 | 49,107 | 49,107 |
| End Cash Position | 189,203 | 72,386 | 71,552 | 55,832 | 83,693 |
| Net Cash Flow | $117,651 | $834 | $22,445 | $6,725 | $34,586 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,314 | -25,519 | 139,803 | 143,816 | 168,308 |
| Capital Expenditure | -1,884 | -838 | -5,614 | -4,638 | -3,190 |
| Free Cash Flow | 12,430 | -26,357 | 134,189 | 139,178 | 165,118 |